| Cynthia Lucas, | |
|
585 S. Riverside Dr, G, Clarksville, TN 37040 | |
| (931) 503-0777 | |
| Not Available |
| Full Name | Cynthia Lucas |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 585 S. Riverside Dr, Clarksville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003025313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia Lucas, 3890 Mackenzie Dr, Clarksville, TN 37042-8643 Ph: (931) 561-4285 | Cynthia Lucas, 585 S. Riverside Dr, G, Clarksville, TN 37040 Ph: (931) 503-0777 |
News Archive
ASTRO's Annual Meeting is the premier scientific meeting in radiation oncology and is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other health care professionals from around the world.
A promising new compound appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the treatment of a host of cancers.
BeaconEquity.com announces an investment report featuring Intellipharmaceutics International Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Nano-photonics expert Shawn Yu-Lin, professor of physics at Rensselaer Polytechnic Institute and a member of the university's Future Chips Constellation and Smart Lighting Engineering Research Center, has been selected as a fellow of the American Association for the Advancement of Science (AAAS).
MAP Pharmaceuticals, Inc. today announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic absorption of LEVADEX was not higher and systemic exposure to DHE was not greater in smokers than in non-smokers.
› Verified 4 days ago
Miss Diane Conley, LADACII, CAP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1725-wilma Rudolph Blvd Ste 1, Clarksville, TN 37040 Phone: 931-221-2839 | |
Mrs. Shelia Carter, MA, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2321 Rudolphtown Rd, Clarksville, TN 37043 Phone: 931-494-6803 | |
Mr. Anthony Russell Saluzzo, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 3320 Carrie Dr, Clarksville, TN 37042 Phone: 931-920-7241 | |
Sara N. Sharp, B.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 611 8th St, Clarksville, TN 37040 Phone: 931-920-7293 | |
Kenneth Jamal Hopson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1820 Memorial Dr, Clarksville, TN 37043 Phone: 931-920-7300 | |
Mrs. Abigail Miller, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1820 Memorial Cir, Clarksville, TN 37043 Phone: 931-920-7333 |